Oxford Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $805K | Buy |
+2,468
| New | +$805K | 0.29% | 81 |
|
|
2024
Q2 | – | Sell |
-1,344
| Closed | -$201K | – | 276 |
|
|
2024
Q1 | $201K | Sell |
1,344
-1,720
| -56% | -$257K | 0.21% | 187 |
|
|
2023
Q4 | $586K | Buy |
+3,064
| New | +$586K | 0.88% | 27 |
|
|
2020
Q1 | – | Sell |
-10,412
| Closed | -$1.2M | – | 256 |
|
|
2019
Q4 | $1.2M | Buy |
10,412
+6,569
| +171% | +$756K | 0.03% | 752 |
|
|
2019
Q3 | $309K | Buy |
+3,843
| New | +$309K | 0.01% | 1442 |
|
|
2017
Q1 | – | Sell |
-19,723
| Closed | -$738K | – | 1386 |
|
|
2016
Q4 | $738K | Sell |
19,723
-21,260
| -52% | -$796K | 0.03% | 526 |
|
|
2016
Q3 | $2.78M | Buy |
+40,983
| New | +$2.78M | 0.09% | 322 |
|
|
2016
Q1 | – | Sell |
-79,126
| Closed | -$7.41M | – | 788 |
|
|
2015
Q4 | $7.41M | Buy |
79,126
+55,296
| +232% | +$5.18M | 0.17% | 118 |
|
|
2015
Q3 | $1.92M | Buy |
+23,830
| New | +$1.92M | 0.06% | 295 |
|
|
2015
Q1 | – | Sell |
-49,594
| Closed | -$4.89M | – | 659 |
|
|
2014
Q4 | $4.89M | Buy |
+49,594
| New | +$4.89M | 0.11% | 207 |
|
|
2013
Q4 | – | Sell |
-249,183
| Closed | -$16M | – | 684 |
|
|
2013
Q3 | $16M | Buy |
249,183
+99,592
| +67% | +$6.37M | 0.36% | 38 |
|
|
2013
Q2 | $4.64M | Buy |
+149,591
| New | +$4.64M | 0.13% | 260 |
|